Healthcare & Wellness AI

Auto Added by WPeMatico

Banner for the AI & Big Data Expo event series.

Insilico Medicine advances AI drug for IPF to Phase III trials

Insilico Medicine is advancing to Phase III human trials for testing a drug identified by AI targeting idiopathic pulmonary fibrosis (IPF). This progression supplies the computational drug discovery sector with empirical test cases, advancing an AI medicine past early safety evaluations into late-stage efficacy validation. IPF destroys respiratory capacity through severe lung tissue scarring. Patients […]

Insilico Medicine advances AI drug for IPF to Phase III trials Read More »

Banner for AI & Big Data Expo by TechEx events.

Takeda signs US$600M AI drug discovery deal with Insilico

Takeda has entered a strategic collaboration with Hong Kong-based Insilico Medicine to use AI in early-stage drug discovery across the Japanese pharmaceutical company’s therapeutic areas. The companies did not disclose which therapeutic areas or disease targets will be covered under the collaboration. The agreement gives Takeda access to Insilico’s Pharma.AI platform, which supports biological target

Takeda signs US$600M AI drug discovery deal with Insilico Read More »

Banner for AI & Big Data Expo by TechEx events.

NVIDIA BioNeMo accelerates Anthropic Claude Science

Anthropic Claude Science now integrates the NVIDIA BioNeMo Agent Toolkit to accelerate computational life sciences research. Anthropic has launched the public beta of Claude Science, an AI workbench built for scientific research. The platform enables scientists to converse directly with digital agents using natural language to execute end-to-end research workflows. This system connects natively to

NVIDIA BioNeMo accelerates Anthropic Claude Science Read More »

JBS Dev: On imperfect data and the AI last mile – from model capability to cost sustainability

Joe Rose, president at strategic technology provider JBS Dev, wants to cut through one of the myths of working with generative and agentic AI systems. “It’s a common misconception that your data has to be perfect before you do any of these types of workloads,” he explains. As a recent article in AI Fieldbook outlines,

JBS Dev: On imperfect data and the AI last mile – from model capability to cost sustainability Read More »

AI helping ease the UK’s NHS burden

The words “pressure” and “NHS” go hand in hand in the UK and unfortunately there is no sign of a reduction in the strain the institution suffers any time soon. As NHS England continues the struggle to reduce its 7.25 million waiting list, new policies are being introduced to move care away from hospitals and

AI helping ease the UK’s NHS burden Read More »

OpenAI Agents SDK improves governance with sandbox execution

OpenAI is introducing sandbox execution that allows enterprise governance teams to deploy automated workflows with controlled risk. Teams taking systems from prototype to production have faced difficult architectural compromises regarding where their operations occurred. Using model-agnostic frameworks offered initial flexibility but failed to fully utilise the capabilities of frontier models. Model-provider SDKs remained closer to

OpenAI Agents SDK improves governance with sandbox execution Read More »

Strengthening enterprise governance for rising edge AI workloads

Models like Google Gemma 4 are increasing enterprise AI governance challenges for CISOs as they scramble to secure edge workloads. Security chiefs have built massive digital walls around the cloud; deploying advanced cloud access security brokers and routing every piece of traffic heading to external large language models through monitored corporate gateways. The logic was

Strengthening enterprise governance for rising edge AI workloads Read More »

How multi-agent AI economics influence business automation

Managing the economics of multi-agent AI now dictates the financial viability of modern business automation workflows. Organisations progressing past standard chat interfaces into multi-agent applications face two primary constraints. The first issue is the thinking tax; complex autonomous agents need to reason at each stage, making the reliance on massive architectures for every subtask too

How multi-agent AI economics influence business automation Read More »

AI forecasting model targets healthcare resource efficiency

An operational AI forecasting model developed by Hertfordshire University researchers aims to improve resource efficiency within healthcare. Public sector organisations often hold large archives of historical data that do not inform forward-looking decisions. A partnership between the University of Hertfordshire and regional NHS health bodies addresses this issue by applying machine learning to operational planning.

AI forecasting model targets healthcare resource efficiency Read More »

Agentic AI in healthcare: How Life Sciences marketing could achieve US$450bn in value by 2028

Agentic AI in healthcare is graduating from answering prompts to autonomously executing complex marketing tasks—and life sciences companies are betting their commercial strategies on it. According to a recent report cited by Capgemini Invent, AI agents could generate up to US$450 billion in economic value through revenue uplift and cost savings globally by 2028, with 69% of

Agentic AI in healthcare: How Life Sciences marketing could achieve US$450bn in value by 2028 Read More »